Author

Hélène Senellart 1

1 Centre René Gauducheau, Oncology, St Herblain, France

CLINICAL, HISTOLOGICAL AND MOLECULAR RISK FACTORS FOR CANCER RECURRENCE IN PATIENTS WITH STAGE II COLON CANCER

Yann Touchefeu, Marie Dewitte, Alain Morel, Isabelle Valo, Jean-François Mosnier, Céline Bossard, Juliette Eugène, Jérôme Chetritt, Stéphane Bézieau, Hélène Senellart, Morgane Caulet, Thierry Lecomte, Estelle Cauchin, Tamara Matysiak-Budnik

HEPATIC ARTERIAL INFUSION CHEMOTHERAPY FOR UNRESECTABLE LIVER METASTASES OF COLORECTAL CANCER: A MULTICENTER RETROSPECTIVE STUDY

Annie Lim, Samuel LE SOURD, Hélène Senellart, Dominique LUET, Frederic Douane, Christophe Perret, Antoine Bouviet, Sylvie Metairie, Estelle Cauchin, Philippe Rougier, Tamara Matysiak-Budnik, Yann Touchefeu

Oxaliplatin and 5-fluorouracil (FOLFOX) in advanced well-differentiated digestive neuroendocrine tumors: a multicenter national retrospective study from the French Group of Endocrine Tumors (GTE)

Paul GIROT, E. Baudin, Hélène Senellart, Nadia Bouarioua, Olivia Hentic-Dhomé, R. Guimbaud, Thomas Walter, Aurélie Ferru, Guillaume Roquin, Guillaume Cadiot, Marc Pracht, Jean-Baptiste Girot, David Malka, Michel Ducreux, Julien Hadoux, Tamara Matysiak Budnik, Yann Touchefeu

SURVIVAL PROGNOSTIC FACTORS OF ENTEROPANCREATIC NEUROENDOCRINE TUMORS: A SINGLE-CENTER RETROSPECTIVE ANALYSIS OF 178 CASES.

Fanny Foubert, Marie-Françoise Heymann, Clotilde Dumars, Hélène Senellart, Tamara Matysiak-Budnik, Yann Touchefeu

Item 1 - 4 / 4
1